 |
|
|
| |
48 Wk Efficacy and Safety of Switching Virologically Stable HIV-1 Patients from Nevirapine IR 200 mg BID to Nevirapine XR 400 mg QD (TRANxITION)
|
| |
| |
Reported by Jules Levin
Glasgow Nov 7-11 2010-11-18
K. Arasteh*, D. Ward, A. Plettenberg, JM, Livrozet, A Winston, C Cordes, E. Wang, A-M. Quinson
* EPIMED c/o Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany
|
| |
|
|
|
|
|
